Gainers
-
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL)
rose 65.5 percent to $179.50 in pre-market trading. Madrigal Pharma disclosed that MGL-3196 achieved liver biopsy endpoints in
patients with NASH at 36 weeks in Phase 2 trial.
-
Viking Therapeutics, Inc. (NASDAQ: VKTX) rose
34.8 percent to $6.70 in pre-market trading after falling 4.42 percent on Wednesday.
-
vTv Therapeutics Inc. (NASDAQ: VTVT) shares rose
31.5 percent to $2.19 in pre-market trading after the company reported a licensing deal with Newsoara Biopharma to rights for
vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
-
Curis, Inc. (NASDAQ: CRIS) shares rose 27.2
percent to $2.90 in pre-market trading after the company reported FDA Fast Track designation for CUDC-907 development in
patients with relapse, refractory diffuse large B-cell lymphoma.
-
Kitov Pharma Ltd (NASDAQ: KTOV) rose 16.7 percent
to $2.51 in pre-market trading.
-
Tilly's, Inc. (NYSE: TLYS) rose 14.7 percent to
$14.00 in pre-market trading as the company reported better-than-expected earnings for its first quarter and issued a strong Q2
outlook.
-
Express, Inc. (NYSE: EXPR) rose 14.3 percent to
$10.49 in pre-market trading after the company reported better-than-expected results for its first quarter.
-
NGL Energy Partners LP (NYSE: NGL) rose 12.8 percent
to $12.10 in pre-market trading after reporting Q4 earnings beat.
-
J.Jill, Inc. (NYSE: JILL) rose 11.3 percent to
$6.90 in pre-market trading after the company posted upbeat quarterly earnings.
-
TapImmune, Inc. (NASDAQ: TPIV) shares rose 10
percent to $5.60 in pre-market trading after climbing 24.15 percent on Wednesday.
-
Frontline Ltd. (NYSE: FRO) rose 9.8 percent to $5.74
in pre-market trading after Q1 results beat estimates.
-
Tech Data Corporation (NASDAQ: TECD) rose 8.8
percent to $89.65 in pre-market trading following better-than-expected Q1 earnings.
-
TransEnterix, Inc. (NYSE: TRXC) shares rose 7.1
percent to $3.65 in pre-market trading. TransEnterix disclosed that LSU Health completed the purchase of its Senhance™ Surgical
System.
-
CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares
rose 6.7 percent to $12.25 in pre-market trading.
-
Huami Corporation (NYSE: HMI) rose 5.5 percent to
$11.50 in pre-market trading.
-
Burlington Stores, Inc. (NYSE: BURL) rose 3.1
percent to $140.70 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY18
outlook.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and
losers
Losers
-
Clearside Biomedical, Inc. (NASDAQ: CLSD) shares
fell 17.8 percent to $11.95 in pre-market trading. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary
and secondary endpoints met in 6-month trial.
-
CRISPR Therapeutics AG (NASDAQ: CRSP) fell 15.8
percent to $62.00 in pre-market trading after the company disclosed that the FDA has placed a clinical hold on IND for CTX001
sickle cell disease treatment.
-
Sears Holdings Corporation (NASDAQ: SHLD) fell 10
percent to $2.89 in pre-market trading after the company posted a loss for the first quarter and announced plans to close 72
non-profitable stores.
-
Urban One, Inc. (NASDAQ: UONE) fell 9 percent to
$3.01 in pre-market trading after rising 78.38 percent on Wednesday.
-
Dollar Tree, Inc. (NASDAQ: DLTR) shares fell 8.6
percent to $88.05 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter and
lowered its FY2018 earnings guidance.
-
Ciena Corporation (NYSE: CIEN) fell 8.5 percent to
$22.02 in the pre-market trading session after the company posted downbeat Q1 earnings and announced plans to buy Packet
Design.
-
Dollar General Corporation (NYSE: DG) shares fell 6.6
percent to $90.11 in pre-market trading after reporting weaker-than-expected results for its first quarter.
-
Vericel Corp (NASDAQ: VCEL) shares fell 6.5
percent to $13.05 in pre-market trading following announcement of 3.75 million share common stock offering.
-
Box, Inc. (NYSE: BOX) fell 5.7 percent to $26.19 in
pre-market trading. Box reported upbeat results for its first quarter. The company forecast Q2 revenue of $146 million to $147
million.
-
Co-Diagnostics, Inc. (NASDAQ: CODX) fell 5.7
percent to $3.15 in pre-market trading after declining 5.65 percent on Wednesday.
-
Cherry Hill Mortgage Investment Corporation (NYSE: CHMI) shares fell 5.2 percent to $18.21 in pre-market trading after reporting a
2.75 million share common stock offering.
-
Cabot Oil & Gas Corporation (NYSE: COG) fell 4.1
percent to $21.76 in pre-market trading after gaining 3.37 percent on Wednesday.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.